Detalhe da pesquisa
1.
Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs.
Proc Natl Acad Sci U S A
; 118(17)2021 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33883278
2.
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Br J Cancer
; 128(12): 2326-2337, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37076563
3.
Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype.
Clin Sci (Lond)
; 135(20): 2393-2408, 2021 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34622923
4.
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Br J Cancer
; 130(5): 892, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38355841
5.
AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Cell Rep
; 42(4): 112396, 2023 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37061917
6.
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation.
Oncogene
; 38(17): 3216-3231, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30626938
7.
CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
Cancer Res
; 78(24): 6747-6761, 2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30242113
8.
AMPK activation protects against diet induced obesity through Ucp1-independent thermogenesis in subcutaneous white adipose tissue.
Nat Metab
; 1(3): 340-349, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30887000